β1-Adrenergic receptor downregulates the expression of cyclooxygenase-2

Biochem Biophys Res Commun. 2014 Aug 22;451(2):319-21. doi: 10.1016/j.bbrc.2014.07.123. Epub 2014 Aug 1.

Abstract

Cyclooxygenase-2 (COX-2) catalyzes the rate-limiting step in the generation of prostanoids, and is thus one of the key players in the inflammatory process. Contrary to the constitutively expressed isoform COX-1, the expression of COX-2 is rapidly and transiently upregulated following pathological stimuli but little is known about pathways that mediate its degradation. Here we show that co-expression of COX-2 together with the β1 adrenergic receptor (β1AR) specifically lowers the expression of COX-2 in a dose-dependent manner. We further find that stimulation of the receptor for prolonged periods of time does not reverse the β1AR-induced decrease in COX-2, suggesting that this effect does not occur via classical β1-mediated signaling pathways. Rather we find that the half-life of COX-2 is significantly decreased in the presence of β1AR and that inhibition of the proteasome reverses the effect of the receptor on COX-2. Together these findings ascribe a new role for β1AR in the downregulation of COX-2.

Keywords: Cyclooxygenase-2; Degradation; β(1) adrenergic receptor.

Publication types

  • Research Support, Non-U.S. Gov't
  • Research Support, U.S. Gov't, Non-P.H.S.

MeSH terms

  • Adrenergic beta-1 Receptor Agonists / pharmacology
  • Cycloheximide / pharmacology
  • Cyclooxygenase 2 / genetics
  • Cyclooxygenase 2 / metabolism*
  • Dobutamine / pharmacology
  • Down-Regulation
  • Enzyme Stability / drug effects
  • HEK293 Cells
  • Half-Life
  • Humans
  • Proteasome Endopeptidase Complex / metabolism
  • Protein Synthesis Inhibitors / pharmacology
  • Proteolysis / drug effects
  • Receptors, Adrenergic, beta-1 / genetics
  • Receptors, Adrenergic, beta-1 / metabolism*
  • Recombinant Proteins / genetics
  • Recombinant Proteins / metabolism
  • Signal Transduction / drug effects

Substances

  • Adrenergic beta-1 Receptor Agonists
  • Protein Synthesis Inhibitors
  • Receptors, Adrenergic, beta-1
  • Recombinant Proteins
  • Dobutamine
  • Cycloheximide
  • Cyclooxygenase 2
  • PTGS2 protein, human
  • Proteasome Endopeptidase Complex